Integrase strand transfer inhibitor (INSTI)-resistance mutations for the surveillance of transmitted HIV-1 drug resistance
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Integrase strand transfer inhibitor (INSTI)-resistance mutations for the surveillance of transmitted HIV-1 drug resistance
Authors
Keywords
-
Journal
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2019-09-12
DOI
10.1093/jac/dkz417
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Resistance to integrase inhibitors: a national study in HIV-1-infected treatment-naive and -experienced patients
- (2019) Anne-Genevieve Marcelin et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Resistance Analysis of Bictegravir/Emtricitabine/Tenofovir Alafenamide in HIV-1 Treatment-Naïve Patients Through 48 Weeks
- (2019) Rima K. Acosta et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The transition to dolutegravir and other new antiretrovirals in low-income and middle-income countries
- (2018) Marco Vitoria et al. AIDS
- Absence of HIV-1 Drug Resistance Mutations Supports the Use of Dolutegravir in Uganda
- (2018) Emmanuel Ndashimye et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Prevalence of Primary Drug Resistance Against HIV-1 Integrase Inhibitors in Canada
- (2018) Hezhao Ji et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Integrase Resistance–Associated Mutations on Raltegravir Failure in Western India
- (2018) Sanjay N. Pujari et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Prevalence and clinical impact of minority resistant variants in patients failing an integrase inhibitor-based regimen by ultra-deep sequencing
- (2018) T Nguyen et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis
- (2018) Ravindra K Gupta et al. LANCET INFECTIOUS DISEASES
- Efficacies of Cabotegravir and Bictegravir against drug-resistant HIV-1 integrase mutants
- (2018) Steven J. Smith et al. Retrovirology
- Integrase Strand Transfer Inhibitor Resistance Mutations in Antiretroviral Therapy-Naïve and Treatment-Experienced HIV Patients in South Korea
- (2018) Wooyong Jeong et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Canary in the Coal Mine? Transmitted Mutations Conferring Resistance to All Integrase Strand Transfer Inhibitors in a Treatment-Naive Patient
- (2018) Kara S McGee et al. Open Forum Infectious Diseases
- Q148N, a Novel Integrase Inhibitor Resistance Mutation Associated with Low-Level Reduction in Elvitegravir Susceptibility
- (2016) Vici Varghese et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Recent trends and patterns in HIV-1 transmitted drug resistance in the United Kingdom
- (2016) A Tostevin et al. HIV MEDICINE
- Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-Analysis
- (2015) Soo-Yon Rhee et al. PLOS MEDICINE
- Lack of resistance to integrase inhibitors among antiretroviral-naive subjects with primary HIV-1 infection, 2007–2013
- (2014) Joanne D Stekler et al. ANTIVIRAL THERAPY
- High frequency of dolutegravir resistance in patients failing a raltegravir-containing salvage regimen
- (2014) J. de Souza Cavalcanti et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Multiple Genetic Pathways Involving Amino Acid Position 143 of HIV-1 Integrase Are Preferentially Associated with Specific Secondary Amino Acid Substitutions and Confer Resistance to Raltegravir and Cross-Resistance to Elvitegravir
- (2013) Wei Huang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Resistance to HIV Integrase Strand Transfer Inhibitors Among Clinical Specimens in the United States, 2009–2012
- (2013) Christopher B. Hurt et al. CLINICAL INFECTIOUS DISEASES
- Non-nucleoside reverse transcriptase inhibitor (NNRTI) cross-resistance: implications for preclinical evaluation of novel NNRTIs and clinical genotypic resistance testing
- (2013) George L. Melikian et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Standardized Comparison of the Relative Impacts of HIV-1 Reverse Transcriptase (RT) Mutations on Nucleoside RT Inhibitor Susceptibility
- (2012) George L. Melikian et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro resistance selections using elvitegravir, raltegravir, and two metabolites of elvitegravir M1 and M4
- (2011) Nicolas A. Margot et al. ANTIVIRAL RESEARCH
- Transmission of integrase strand-transfer inhibitor multidrug-resistant HIV-1: case report and response to raltegravir-containing antiretroviral therapy
- (2011) Benjamin Young et al. ANTIVIRAL THERAPY
- Transmitted raltegravir resistance in an HIV-1 CRF_AG-infected patient
- (2011) Sarita D Boyd et al. ANTIVIRAL THERAPY
- Cross-resistance Profile of the Novel Integrase Inhibitor Dolutegravir (S/GSK1349572) Using Clonal Viral Variants Selected in Patients Failing Raltegravir
- (2011) Filippo Canducci et al. JOURNAL OF INFECTIOUS DISEASES
- Efficacy and safety of once daily elvitegravir versus twice daily raltegravir in treatment-experienced patients with HIV-1 receiving a ritonavir-boosted protease inhibitor: randomised, double-blind, phase 3, non-inferiority study
- (2011) Jean-Michel Molina et al. LANCET INFECTIOUS DISEASES
- Structural and Functional Analyses of the Second-Generation Integrase Strand Transfer Inhibitor Dolutegravir (S/GSK1349572)
- (2011) S. Hare et al. MOLECULAR PHARMACOLOGY
- HIV-1 Protease Mutations and Protease Inhibitor Cross-Resistance
- (2010) S.-Y. Rhee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroAntiretroviral Properties of S/GSK1349572, a Next-Generation HIV Integrase Inhibitor
- (2010) Masanori Kobayashi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Resistance to HIV-1 integrase inhibitors: A structural perspective
- (2010) Jean-François Mouscadet et al. DRUG RESISTANCE UPDATES
- Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update
- (2009) Diane E. Bennett et al. PLoS One
- Preclinical Evaluation of GS-9160, a Novel Inhibitor of Human Immunodeficiency Virus Type 1 Integrase
- (2008) G. S. Jones et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More